Derek DiRocco
CIK 1792061 · last filed 2026-05-20
Derek DiRocco is a corporate insider who has filed 25 SEC Form 4 insider transactions across 5 companies since 2020. The most recent filing, for ACRV, was dated May 20, 2026. Current disclosed insider exposure totals $160.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$160.3K
5
25
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRV | Director | 9,366 | $1.48 | $13.9K | $0 | 4 | 2026-05-20 |
| MLYS | Director | 6,200 | $23.62 | $146.4K | $0 | 4 | 2026-02-20 |
| 89bio, Inc. (ETNB) Delisted | Director | — | $14.84 | — | $0 | 8 | 2025-10-30 |
| HOWL | Director | — | $0.38 | — | $0 | 4 | 2024-05-24 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | — | $10.15 | — | $0 | 5 | 2023-06-15 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | ACRV | Grant (A) | +9,366 | $0 | EDGAR |
| 2026-02-20 | MLYS | Grant (A) | +6,200 | $0 | EDGAR |
| 2025-10-30 | 89bio, Inc. (ETNB) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-17 | ACRV | Grant (A) | — | $0 | EDGAR |
| 2025-02-24 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2025-02-05 | 89bio, Inc. (ETNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | ACRV | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | HOWL | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2024-02-05 | 89bio, Inc. (ETNB) Delisted | Grant (A) | — | $0 | EDGAR |